Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their...
Aerpio Pharmaceuticals’ Merger with Aadi Bioscience
Sonder’s Business Combination with Gores Metropoulos II
Wilson Sonsini Goodrich & Rosati advised Sonder Holdings on the deal, while Weil advised Gores Metropoulos II, Inc. Sonder Holdings, a leading next-generation hospitality company that...
Applied Molecular Transport’s $105 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...
Everlywell’s Acquisition of PWNHealth and Home Access Health Corporation
Wilson Sonsini Goodrich & Rosati advised Everlywell on the deal, while Choate represented PWNHealth. Everlywell, a leading digital health company, announced that it has acquired PWNHealth...
First High-School Education Group’s US$75 Million IPO
Wilson Sonsini Goodrich & Rosati and Maples and Calder advised First High-School Education Group Co. on the deal. Kirkland & Ellis International LLP acted as US...
NuVasive’s Acquisition of Simplify Medical
Wilson Sonsini Goodrich & Rosati advised Simplify Medical on the deal. NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally...